ÂÜÀòÂÒÂ×

Michael Murray is currently an observer at Palvella Therapeutics. Prior to that, they worked as an associate at Leerink Partners LLC from September 2010 to May 2013. At Leerink, they worked with leading and emerging life sciences companies to develop and implement growth strategies.